Beyond direct tumour killing, CAR‐iNKTs contribute to host immunity by cross‐priming CD8+ T cells,107 depleting immunosuppressive CD1d+ TAMs and MDSCs,165, 166 activating DCs, and promoting epitope spreading.108. Here, CD8A is linked to neoplasm.